Hamamatsu to Resell Visiopharm Products
Visiopharm and Hamamatsu have announced a nonexclusive worldwide OEM agreement and reseller partnership for Visiopharm’s quantitative digital pathology (QDP) solutions.
Under the agreement, Visiopharm will serve as an OEM for Hamamatsu’s NDP.Analyze software, a research tool for tissue image analysis that is fully compatible with Visiopharm’s suite of QDP solutions. Hamamatsu will market and sell the suite of QDP solutions, including CloudAnalysis, DeployedAnalysis, Stereology and Application Protocol Packages from Visiopharm’s new APPCenter.
Hamamatsu, which is known for its NanoZoomer Digital Pathology (NDP) whole slide scanners, will expand its offering to include quantitative digital pathology. The full range of analysis solutions are integrated with the NDP.serve data management software, which is available directly from Hamamatsu.
For more information, visit:
www.hamamatsu.com
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024